Skip to main content

Table 3 Purpose and schedule of assessments in BeneMin

From: The benefit of minocycline on negative symptoms in early-phase psychosis in addition to standard care - extent and mechanism (BeneMin): study protocol for a randomised controlled trial

 

Screening

Randomisation (Pre-treatment)

Month 2

Month 6

Month 9

Month 12 (Post-treatment)

Month 15 (Post-trial)

Inclusion and exclusion criteria checklist

EM

      

Case-note diagnostic checklist

EM

      

Diagnostic and eligibility checklist

EM and CO

    

CO

 

Mini-International Neuropsychiatric Interview

EM and CO

    

CO

 

Positive and Negative Syndrome Scale

EM and CO

CO

CO

CO

CO

CO

CO

Wechsler Adult Intelligence Scale III; 4 subtest short form

EM and CO

    

CO

CO

Wechsler Test of Adult Reading

EM and CO

      

Verbal fluency

EM and CO

    

CO

CO

Auditory-Verbal Learning Task

EM and CO

    

CO

CO

Medication treatment history

EM and CO

CO

CO

CO

CO

CO

CO

Pregnancy urine dipstick test

EM

WCM

WCM

WCM

WCM

WCM

 

Drug urine screening test

EM

  

WCM

   

Drug use questionnaire

EM

WCM

WCM

WCM

WCM

WCM

SCo

Blood laboratory screening for kidney and liver function

EM

    

WCM

 

Blood pressure and heart rate

EM

    

WCM

SCo

MRI screening questionnaire

EM

      

Duration of untreated psychosis

RP

      

Body weight and body mass index

 

CO

   

CO

CO

Global Assessment of Functioning

 

CO

CO

CO

CO

CO

CO

Social Functioning Scale

 

CO

 

CO

 

CO

CO

MRI scanning

 

BO

   

BO

 

Blood cytokine screen test

 

BO

 

BO

 

BO

BO

Saliva Oragene kit for DNA donation

 

RP

     

Withdrawal criteria checklist

 

WCM

WCM

WCM

WCM

WCM

 

Calgary Depression Scale for Schizophrenia

 

SCo

SCo

SCo

SCo

SCo

SCo

Simpson and Angus Scale

 

SCo

 

SCo

 

SCo

SCo

Barnes Akathisia Scale

 

SCo

 

SCo

 

SCo

SCo

Abnormal Involuntary Movements Scale

 

SCo

 

SCo

 

SCo

SCo

Antipsychotic Non-Neurological Side-Effects Rating Scale

 

SCo

SCo

SCo

SCo

SCo

SCo

7-point compliance scale

  

AT

AT

AT

AT

 
  1. EM, eligibility measure; CO, clinical outcome; RP, response predictor; BO, biomarker outcome; WCM, withdrawal criteria measure; SCo, side-effects and co-morbidity; AT, adherence to treatment.
  2. Intersections between lines and columns show if the test took place during the visit (cells containing an abbreviation). Abbreviations explicate the reason why the test was performed at a particular stage of the trial and how the particular measure fits into statistical design of the study.